Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Raas Blood Products Co., Ltd.

Clinical trials sponsored by Shanghai Raas Blood Products Co., Ltd., explained in plain language.

Shanghai RAAS Blood Products Co., Ltd. 002252 SZSE

A Chinese blood products company manufacturing plasma-derived therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1

New injection aims to curb bleeding in rare clotting disorder

Disease control Not yet recruiting

This phase II trial tests an injected drug called SR604 in people with congenital Factor VII deficiency, a rare bleeding disorder. The goal is to see if SR604 can reduce the number of bleeding episodes and improve safety. The study includes 12 participants aged 12 to 65 who have …

Phase: PHASE2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC